Dr. Taesik Gwag, along with Dr. Changcheng Zhou and colleagues from the Zhou lab have an article in the Journal of Hepatology entitled "Non-nucleoside reverse transcriptase inhibitor efavirenz activates PXR to induce hypercholesterolemia and hepatic steatosis". Other co-authors include faculty colleagues Drs. Shuxia Wang, from our department, and R Greenberg of UK's Internal Medicine. The article deals with novel approaches to overcoming cardiovascular risks imparted by anti-viral therapies used in the treatment of HIV. Kudos to the Zhou Lab and colleagues! A link to the article can be found at https://www.journal-of-hepatology.eu/article/S0168-8278(19)30029-7/fulltext
Zhou Liver.png